Blood Tests to Monitor While Taking JAK Inhibitors

Learn about essential blood tests to monitor when taking JAK inhibitors like tofacitinib, upadacitinib, and baricitinib.

Oct 27, 2026 2 min read

Taking JAK inhibitors, a class of medications used to treat certain inflammatory conditions, requires careful monitoring through specific blood tests. These medications can affect blood cell counts and other important health markers, making regular testing crucial for safe treatment.

What Are JAK Inhibitors?

JAK inhibitors, or Janus kinase inhibitors, are a type of medication used to treat autoimmune diseases such as rheumatoid arthritis. They work by blocking the activity of Janus kinase enzymes, which play a role in the inflammatory process. By inhibiting these enzymes, JAK inhibitors help reduce inflammation and alleviate symptoms.

Have your own lab results? Upload your report and get a clear, private AI explanation in minutes, in English, Russian or Hebrew.
Analyze my results

Key Blood Tests for Tofacitinib

When taking tofacitinib, a specific type of JAK inhibitor, several blood tests are essential:

  • Complete Blood Count (CBC): This test checks your white blood cells, red blood cells, and platelets. It's important to ensure your lymphocyte count is not below 500 cells/mm³, and your absolute neutrophil count (ANC) is not below 1000 cells/mm³. Low counts can increase the risk of infections.
  • Liver Function Tests: Routine liver tests are recommended to monitor the liver's health while on tofacitinib.
  • Lipid Profile: This test measures cholesterol levels. Tofacitinib can cause increases in total, LDL, and HDL cholesterol, with changes typically seen within six weeks of starting the medication.

Monitoring Schedule for Tofacitinib

For tofacitinib, specific monitoring schedules are suggested:

  • Lymphocytes: Check at baseline and every three months. An initial increase may occur at one month, followed by a gradual decline over a year.
  • Neutrophils and Hemoglobin: Monitor at baseline, then after 4 to 8 weeks, and every three months.
  • Lipids: Assess about 4 to 8 weeks after starting treatment.

Monitoring Other JAK Inhibitors

Other JAK inhibitors like upadacitinib and baricitinib have similar monitoring requirements:

  • Blood Cell Counts and Liver Enzymes: Evaluate at baseline and according to routine patient management.
  • Lipids: Assess about 12 weeks after starting.

Frequently Asked Questions

What happens if my blood counts are low while on JAK inhibitors? If your lymphocyte count falls below 500 cells/mm³ or your ANC drops below 1000 cells/mm³, treatment may need to be paused or adjusted to reduce the risk of serious infections.

Are there any specific dietary restrictions while taking JAK inhibitors? There are no specific dietary restrictions, but maintaining a healthy diet can support overall health. Always discuss any concerns with your healthcare provider.

Can JAK inhibitors affect my cholesterol levels? Yes, JAK inhibitors like tofacitinib can cause increases in cholesterol levels. Regular monitoring through lipid profiles is recommended.

When to See a Doctor

You should consult your doctor if you notice any unusual symptoms such as persistent fatigue, frequent infections, or unexplained bruising. These could indicate changes in your blood cell counts. Additionally, regular follow-ups with your healthcare provider are essential to ensure safe and effective treatment.

This information is intended to provide a general understanding of blood tests related to JAK inhibitors. Always consult your healthcare provider for personal medical advice.

Read this in another language

Have your own lab results? Upload your report and get a clear, private AI explanation in minutes, in English, Russian or Hebrew.
Analyze my results